Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| TG3-H52H5 | Human | Human Latent TGF-beta 3 / Latent TGFB3 Protein, His Tag |  |
|
|
| TG3-H82E6 | Human | Biotinylated Human Latent TGF-beta 3 / Latent TGFB3 Protein, His,Avitag™ |  |
|
|
| TG3-H5213 | Human | Human TGF-beta 3 / TGFB3 Protein, premium grade |  |
|
|
Immobilized Human TGFBR2, Fc Tag (Cat. No. TG2-H5252) at 5 μg/mL (100 μL/well) can bind Biotinylated Human Latent TGFB3, His,Avitag (Cat. No. TG3-H82E6) with a linear range of 0.3-20 ng/mL (QC tested).
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Dalutrafusp alfa | GS-1423; AGEN-1423 | Phase 2 Clinical | Agenus Inc | Solid tumours; Liver Neoplasms; Pancreatic Neoplasms; Colorectal Neoplasms; Carcinoma, Pancreatic Ductal | Details |
| RG-6315 | RG-6315 | Phase 1 Clinical | Genentech Inc | Scleroderma, Systemic | Details |
| AVID-200 | AVID-200; BMS-986416; AVID-200 DP | Phase 1 Clinical | Formation Biologics Corp | Solid tumours; Polycythemia Vera; Primary Myelofibrosis; Scleroderma, Diffuse; Thrombocythemia, Essential | Details |
This web search service is supported by Google Inc.
A-Z
